-
1.发明申请Compounds useful in treating diabetic microvascular complications and age-related macular degeneration 审中-公开可用于治疗糖尿病微血管并发症和年龄相关性黄斑变性的化合物公开(公告)号：US20070298997A1
公开(公告)日：2007-12-27
申请号：US11703326
申请日：2007-02-07
Applicant: Jian-xing Ma
Inventor： Jian-xing Ma
CPC classification number: A61K38/57
Abstract: The present invention is directed to a method of treating microvascular complications associated with diabetes and age-related macular degeneration. The methods include administering to an animal in need thereof an effective amount of a composition, wherein the composition is selected from the group consisting of kallistatin, fragments of kallistatin, analogs or derivatives of kallistatin, and combinations thereof.
Abstract translation: 本发明涉及治疗与糖尿病和年龄相关性黄斑变性相关的微血管并发症的方法。 所述方法包括向有需要的动物施用有效量的组合物，其中所述组合物选自卡立司他胺，卡列斯汀的片段，卡列他汀的类似物或衍生物及其组合。
-
2.发明申请Compounds useful in inhibiting vascular leakage, inflammation and fibrosis and methods of making and using same 审中-公开可用于抑制血管渗漏，炎症和纤维化的化合物及其制备和使用方法公开(公告)号：US20060189534A1
公开(公告)日：2006-08-24
申请号：US11397286
申请日：2006-04-04
Applicant: Jian-xing Ma
Inventor： Jian-xing Ma
IPC: A61K38/17
CPC classification number: A61K38/57
Abstract: The present invention is directed to a method of inhibiting at least one of vascular leakage, angiogenesis, inflammation and fibrosis in an animal by administering to the animal an effective amount of a composition, wherein the composition is selected from the group consisting of kallistatin, fragments of kallistatin, analogs or derivatives of kallistatin, and combinations thereof.
Abstract translation: 本发明涉及一种通过向动物施用有效量的组合物来抑制动物血管渗漏，血管生成，炎症和纤维化中的至少一种的方法，其中所述组合物选自卡立司他汀，片段 卡列斯汀，卡拉司他汀的类似物或衍生物及其组合。
-
3.发明申请Compounds useful in inhibiting vascular leakage, inflammation and fibrosis and methods of making and using same 审中-公开可用于抑制血管渗漏，炎症和纤维化的化合物及其制备和使用方法公开(公告)号：US20050130897A1
公开(公告)日：2005-06-16
申请号：US11010794
申请日：2004-12-13
Applicant: Jian-xing Ma
Inventor： Jian-xing Ma
CPC classification number: A61K38/57
Abstract: The present invention is directed to a method of inhibiting at least one of vascular leakage, angiogenesis, inflammation and fibrosis in an animal by administering to the animal an effective amount of a composition, wherein the composition is selected from the group consisting of kallistatin, fragments of kallistatin, analogs or derivatives of kallistatin, and combinations thereof.
Abstract translation: 本发明涉及一种通过向动物施用有效量的组合物来抑制动物血管渗漏，血管生成，炎症和纤维化中的至少一种的方法，其中所述组合物选自卡立司他汀，片段 卡列斯汀，卡拉司他汀的类似物或衍生物及其组合。
-
-
Search Results
3
records
(took 0.013 seconds)
